Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia.

Journal Academic Article, Review

A diverse range of drug delivery vehicles have been developed to specifically target chemotherapeutics to solid tumours while avoiding systemic dose-limiting toxicity. Many of these active targeting strategies display limited efficacy because they rely on subtle differences in expression patterns between pathogenic tissue and healthy tissue. In contrast, drug delivery systems that exploit thermoresponsive behaviour allow a clinician to spatially and temporally control the accumulation and/or release of the toxic agents within tumour tissue by simply applying mild hyperthermia (defined as 39-43 °C) to the desired site. Although thermally sensitive materials comprise a significant portion of the literature on novel drug delivery systems, only a few systems have been methodically tuned to respond within this narrowly defined physiological temperature range in an in vivo environment. This review discusses the materials and strategies developed to control the primary tumour through the combined application of hyperthermia and chemotherapy.

Full Text

Duke Authors

Cited Authors

  • McDaniel, JR; Dewhirst, MW; Chilkoti, A

Published Date

  • September 2013

Published In

Volume / Issue

  • 29 / 6

Start / End Page

  • 501 - 510

PubMed ID

  • 23924317

Electronic International Standard Serial Number (EISSN)

  • 1464-5157

Digital Object Identifier (DOI)

  • 10.3109/02656736.2013.819999

Language

  • eng

Citation Source

  • PubMed